Tumor suppression by p53: making cells senescent.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical mechanisms without primary human data
PubMed 20183804 · doi:10.14670/HH-25.515
What was done
This is a narrative review describing the molecular mechanisms by which the transcription factor p53 regulates cellular senescence to suppress tumorigenesis, summarizing preclinical animal findings and comparing p53 with its homologs p63 and p73.
What was found
The abstract provides no numerical data or statistical metrics. It reports qualitatively that p53 restoration induces premature senescence and tumor regression in mouse models of hepatocarcinoma and sarcoma, demonstrating in vivo cancer cell clearance, whereas the precise roles of p63 and p73 in senescence remain unestablished.
Why it matters
The paper outlines how p53-mediated senescence functions as an active in vivo tumor elimination mechanism, highlighting potential pathways for cancer intervention.
Limits
The abstract describes a narrative synthesis lacking systematic review methodology, reports no quantitative outcomes or sample sizes, and draws conclusions strictly from preclinical bench and animal models without human clinical data.
Cited by
- supports Mutations in genes that regulate senescence-associated cell growth arrest lead to early cancer-related death in both mice and humans.